Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Ciclosporin
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Neoral 50mg capsules
0802020G0BCACAF
|
Neoral | Ciclosporin | Malignant Disease and Immunosuppression | 4,639 |
|
Neoral 25mg capsules
0802020G0BCABAC
|
Neoral | Ciclosporin | Malignant Disease and Immunosuppression | 3,529 |
|
Neoral 100mg capsules
0802020G0BCADAD
|
Neoral | Ciclosporin | Malignant Disease and Immunosuppression | 2,318 |
|
Ciclosporin 50mg capsules
0802020G0AAAFAF
|
Ciclosporin (Systemic) | Ciclosporin | Malignant Disease and Immunosuppression | 466 |
|
Ciclosporin 100mg capsules
0802020G0AAADAD
|
Ciclosporin (Systemic) | Ciclosporin | Malignant Disease and Immunosuppression | 330 |
|
Ciclosporin 25mg capsules
0802020G0AAACAC
|
Ciclosporin (Systemic) | Ciclosporin | Malignant Disease and Immunosuppression | 299 |
|
Deximune 50mg capsules
0802020G0BEABAF
|
Deximune | Ciclosporin | Malignant Disease and Immunosuppression | 254 |
|
Deximune 100mg capsules
0802020G0BEACAD
|
Deximune | Ciclosporin | Malignant Disease and Immunosuppression | 221 |
|
Deximune 25mg capsules
0802020G0BEAAAC
|
Deximune | Ciclosporin | Malignant Disease and Immunosuppression | 199 |
|
Capimune 100mg capsules
0802020G0BFACAD
|
Capimune | Ciclosporin | Malignant Disease and Immunosuppression | 197 |
|
Capimune 50mg capsules
0802020G0BFABAF
|
Capimune | Ciclosporin | Malignant Disease and Immunosuppression | 174 |
|
Neoral 100mg/ml oral solution
0802020G0BCAAAG
|
Neoral | Ciclosporin | Malignant Disease and Immunosuppression | 167 |
|
Neoral 10mg capsules
0802020G0BCAEAH
|
Neoral | Ciclosporin | Malignant Disease and Immunosuppression | 139 |
|
Capimune 25mg capsules
0802020G0BFAAAC
|
Capimune | Ciclosporin | Malignant Disease and Immunosuppression | 134 |
|
Capsorin 100mg capsules
0802020G0BGAAAD
|
Capsorin | Ciclosporin | Malignant Disease and Immunosuppression | 98 |
|
Capsorin 50mg capsules
0802020G0BGABAF
|
Capsorin | Ciclosporin | Malignant Disease and Immunosuppression | 89 |
|
Capsorin 25mg capsules
0802020G0BGACAC
|
Capsorin | Ciclosporin | Malignant Disease and Immunosuppression | 83 |
|
Vanquoral 50mg capsules
0802020G0BHABAF
|
Vanquoral | Ciclosporin | Malignant Disease and Immunosuppression | 56 |
|
Vanquoral 25mg capsules
0802020G0BHAAAC
|
Vanquoral | Ciclosporin | Malignant Disease and Immunosuppression | 49 |
|
Vanquoral 100mg capsules
0802020G0BHACAD
|
Vanquoral | Ciclosporin | Malignant Disease and Immunosuppression | 48 |
|
Ciclosporin 100mg/ml oral solution sugar free
0802020G0AAAGAG
|
Ciclosporin (Systemic) | Ciclosporin | Malignant Disease and Immunosuppression | 23 |
|
Ciclosporin 10mg capsules
0802020G0AAAHAH
|
Ciclosporin (Systemic) | Ciclosporin | Malignant Disease and Immunosuppression | 22 |
|
Sandimmun 50mg capsules
0802020G0BBAFAF
|
Sandimmun | Ciclosporin | Malignant Disease and Immunosuppression | 14 |
|
Sandimmun 25mg capsules
0802020G0BBADAC
|
Sandimmun | Ciclosporin | Malignant Disease and Immunosuppression | 8 |
|
Sandimmun 100mg capsules
0802020G0BBAEAD
|
Sandimmun | Ciclosporin | Malignant Disease and Immunosuppression | 6 |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.